Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-08-23

FDA Approved: EPIPEN — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for EPIPEN (epinephrine autoinjector) from Viatris Specialty LLC, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EpiPen (epinephrine)

Snippet

SUPPL AP for EPIPEN (EPINEPHRINE)